Marcum Wealth’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $526K | Sell |
4,696
-609
| -11% | -$68.2K | 0.05% | 187 |
|
|
2024
Q4 | $490K | Sell |
5,305
-448
| -8% | -$41.4K | 0.04% | 202 |
|
|
2024
Q3 | $482K | Buy |
5,753
+1,208
| +27% | +$101K | 0.04% | 205 |
|
|
2024
Q2 | $312K | Sell |
4,545
-165
| -4% | -$11.3K | 0.03% | 264 |
|
|
2024
Q1 | $345K | Sell |
4,710
-300
| -6% | -$22K | 0.04% | 244 |
|
|
2023
Q4 | $406K | Buy |
5,010
+457
| +10% | +$37K | 0.04% | 208 |
|
|
2023
Q3 | $341K | Buy |
4,553
+848
| +23% | +$63.5K | 0.04% | 220 |
|
|
2023
Q2 | $286K | Sell |
3,705
-517
| -12% | -$39.8K | 0.03% | 257 |
|
|
2023
Q1 | $350K | Sell |
4,222
-1,361
| -24% | -$113K | 0.04% | 224 |
|
|
2022
Q4 | $479K | Sell |
5,583
-218
| -4% | -$18.7K | 0.06% | 172 |
|
|
2022
Q3 | $358K | Buy |
5,801
+276
| +5% | +$17K | 0.05% | 206 |
|
|
2022
Q2 | $342K | Buy |
5,525
+669
| +14% | +$41.4K | 0.05% | 216 |
|
|
2022
Q1 | $289K | Buy |
4,856
+470
| +11% | +$28K | 0.04% | 249 |
|
|
2021
Q4 | $318K | Sell |
4,386
-193
| -4% | -$14K | 0.04% | 238 |
|
|
2021
Q3 | $320K | Buy |
4,579
+645
| +16% | +$45.1K | 0.05% | 228 |
|
|
2021
Q2 | $271K | Buy |
3,934
+201
| +5% | +$13.8K | 0.04% | 233 |
|
|
2021
Q1 | $241K | Buy |
+3,733
| New | +$241K | 0.04% | 253 |
|